Deficient insulin signaling in the PI3K/Akt pathway that allows pathological activation of GSK3β has been proposed as a common denominator that links MetS with tau hyperphosphorylation at these epitopes (15, 19, 20, 26–28, 75, 92–96). This evidence concerns the gene AKT1 and metabolic syndrome.